Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ahn

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Blood|November 29, 2019
Cardiovascular adverse events of ibrutinibInhye E Ahn
Acta Haematologica|September 13, 2023
Prognostic Markers in the Era of Targeted TherapiesSorang Kang, Inhye E Ahn
Seminars in Oncology|January 8, 2017
Controversies in multiple myeloma: Evidence-based updateInhye E Ahn, Sham Mailankody
Frontiers in Immunology|July 12, 2021
Targeting Bruton's Tyrosine Kinase in CLLInhye E Ahn, Jennifer R Brown
Journal of Clinical Pathology|December 1, 2009
Drug-related cardiac pathologyJ Butany, E Ahn, A Luk
Hematology. American Society of Hematology. Education Program|December 9, 2022
Selecting initial therapy in CLLInhye E Ahn, Jennifer R Brown
Seminars in Hematology|March 27, 2024
Therapeutic targeting of apoptosis in chronic lymphocytic leukemiaInhye E Ahn, Matthew S Davids
Hematology. American Society of Hematology. Education Program|December 10, 2017
Safety profiles of novel agent therapies in CLLInhye E Ahn, Matthew S Davids
International Journal of Clinical Rheumatology|June 28, 2012
Fatigue in systemic lupus erythematosusGrace E Ahn, Rosalind Ramsey-Goldman
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelideInhye E Ahn, Ethan Natelson, Lawrence Rice
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Blood|November 29, 2019
Cardiovascular adverse events of ibrutinibInhye E Ahn
Acta Haematologica|September 13, 2023
Prognostic Markers in the Era of Targeted TherapiesSorang Kang, Inhye E Ahn
Seminars in Oncology|January 8, 2017
Controversies in multiple myeloma: Evidence-based updateInhye E Ahn, Sham Mailankody
Frontiers in Immunology|July 12, 2021
Targeting Bruton's Tyrosine Kinase in CLLInhye E Ahn, Jennifer R Brown
Journal of Clinical Pathology|December 1, 2009
Drug-related cardiac pathologyJ Butany, E Ahn, A Luk
Hematology. American Society of Hematology. Education Program|December 9, 2022
Selecting initial therapy in CLLInhye E Ahn, Jennifer R Brown
Seminars in Hematology|March 27, 2024
Therapeutic targeting of apoptosis in chronic lymphocytic leukemiaInhye E Ahn, Matthew S Davids
Hematology. American Society of Hematology. Education Program|December 10, 2017
Safety profiles of novel agent therapies in CLLInhye E Ahn, Matthew S Davids
International Journal of Clinical Rheumatology|June 28, 2012
Fatigue in systemic lupus erythematosusGrace E Ahn, Rosalind Ramsey-Goldman
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelideInhye E Ahn, Ethan Natelson, Lawrence Rice
Pageof 13